Leslie Lee
Westchester Medical Center(US)Stanford Medicine(US)Stanford University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Intraoperative Neuromonitoring and Anesthetic Effects, Medical Imaging and Pathology Studies
Most-Cited Works
- → GDC-0449—A potent inhibitor of the hedgehog pathway(2009)385 cited
- → Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models(2016)308 cited
- → GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway(2011)227 cited
- → Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors(2012)184 cited
- → Discovery of 2-{3-[2-(1-Isopropyl-3-methyl-1H-1,2–4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide (GDC-0032): A β-Sparing Phosphoinositide 3-Kinase Inhibitor with High Unbound Exposure and Robust in Vivo Antitumor Activity(2013)175 cited
- → Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas(2012)135 cited